(Q35541562)

8 August 2017

1 reference

title

Compared pharmacological characteristics in humans of racemic cetirizine and levocetirizine, two histamine H1-receptor antagonists (English)

1 reference

8 August 2017

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(03)00558-6

13 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(03)00558-6

13 March 2024

2

Bernard Testa

1 reference

8 August 2017

Jean-Paul Tillement

1

1 reference

8 August 2017

Françoise Brée

series ordinal

3

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 October 2003

1 reference

full work available at URL

8 August 2017

https://api.elsevier.com/content/article/PII:S0006295203005586?httpAccept=text/xml

1 reference

DOI

https://api.crossref.org/works/10.1016/S0006-2952(03)00558-6

https://api.elsevier.com/content/article/PII:S0006295203005586?httpAccept=text/plain

13 March 2024

1 reference

DOI

https://api.crossref.org/works/10.1016/S0006-2952(03)00558-6

13 March 2024

published in

Biochemical Pharmacology

1 reference

8 August 2017

volume

66

1 reference

8 August 2017

issue

7

1 reference

8 August 2017

page(s)

1123-1126

1 reference

New insights into the second generation antihistamines

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900558-6

In vitro inhibition of human liver drug metabolizing enzymes by second generation antihistamines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900558-6

Racemates versus enantiomers in drug development: dogmatism or pragmatism?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900558-6

Binding characteristics of cetirizine and levocetirizine to human H(1) histamine receptors: contribution of Lys(191) and Thr(194).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900558-6

A randomized, double-blind, crossover comparison among cetirizine, levocetirizine, and ucb 28557 on histamine-induced cutaneous responses in healthy adult volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900558-6

Effect of cetirizine, levocetirizine, and dextrocetirizine on histamine-induced nasal response in healthy adult volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900558-6

Absorption and disposition of levocetirizine, the eutomer of cetirizine, administered alone or as cetirizine to healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900558-6

Absorption, distribution, metabolism and excretion of [14C]levocetirizine, the R enantiomer of cetirizine, in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900558-6

Second-generation antihistamines: a comparative review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900558-6

Cetirizine. A review of its pharmacological properties and clinical potential in allergic rhinitis, pollen-induced asthma, and chronic urticaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900558-6

The metabolism of antihistamines and drug interactions: the role of cytochrome P450 enzymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900558-6

Molecular properties and pharmacokinetic behavior of cetirizine, a zwitterionic H1-receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900558-6

A low distribution volume as a determinant of efficacy and safety for histamine (H1 antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900558-6

Blood distribution of levocetirizine, a new non-sedating histamine H1-receptor antagonist, in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900558-6

Double-blind comparison of cetirizine and loratadine in children ages 2 to 6 years with perennial allergic rhinitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900558-6

7 January 2021

Identifiers

DOI

1 reference

8 August 2017

1 reference